3 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
Follow 2-mercaptopurine: new trials by email Literature Review of 2-mercaptopurine trials Research Report on 2-mercaptopurine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Management of Moderate POstoperative Recurrence in Crohn's Disease: a randoMizEd contROLled Trial of Therapeutic Escalation, the POMEROL Trial. (POMEROL) Infliximab CT-P13, Immunosuppressors (Thiopurines or Methotrexate) - Crohn Disease | Phase 4 | Unknown | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 360 | 2021-12-21 | 2022-08-04 |
| Stricture Definition and Treatment (STRIDENT) Drug Therapy Study Adalimumab Injection, Thiopurine, Endoscopic balloon dilatation - Crohn Disease, Inflammatory Bowel Diseases | Phase 4 | Unknown | St Vincent's Hospital Melbourne | 78 | 2017-10-09 | 2020-10-23 |
| The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease Infliximab, thiopurine - Inflammatory Bowel Disease, Crohn's Disease | Unknown | Ernest Seidman | 225 | 2014-11-17 | 2017-02-16 |
Crohn Disease (3) · Inflammatory Bowel Diseases (2) · Constriction, Pathologic (1)
Ernest Seidman (1) · Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives (1) · St Vincent's Hospital Melbourne (1)
Australia (1) · Canada (1) · France (1)
Bronte Holt, MBBS PhD (1) · Emily Wright, MBBS PhD (1) · Ernest Seidman, MDCM (1) · Michael Kamm, MBBS PhD (1)